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Persistent puhnonary hypertension of the neonate in a
developing country - does extracorporeal metnbrane
oxygenation have a role to play?
J. SMITH, G. F. KIRSTEN
Abstract A retrospective study was undertaken of survival
after conventional Inanagement of 35 infants suf-
fering from persistent pubnonary hypertension of
the neonate (PPHN). The outcOIne of infants
weighing Inore than 2 000 g and who also qualified
for extracorporeal membrane oxygenation
(ECMO) therapy on the grounds of published cri-
teria was assessed.
The admission incidence ofpatients with PPHN
was 1,10/0. Secondary PPHN was Inore COInInon
than primary. The overall survival rate of 69% in
this study reflects the trend in recently reported
iInproved survival rates of infants with PPHN,
treated with conventional techniques. Sixteen of 28
infants weighing Inore than 2 000 g qualified for
ECMO therapy; 4 of them died. Had ECMO been
available as an alternative Inode of therapy, only 2
of the 4 Inight have been saved. The other 2 were
considered to have conditions incoInpatible with a
nOrInal quality of life. We therefore assessed the
requireInent for ECMO in our population to be
approxiInately 0,6/1 000 live births. Although
ECMO Inay be proInising, the introduction of this
technique in developing countries should rather be
delayed until Inore substantial data refute this.
Because PPHN could be related to a potential pre-
ventable cause in almost 800/0 of cases, we propose
the support of more cost-effective strategies such
as continuing obstetric and perinatal education
prograInInes.
S Atr Med J 1993; 83: 742-745.
Persistent pulmonary hypertension of the neonate(PPHN) is a syndrome in which severe hypox-aemia and right-to-left shunting of blood through
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the foramen ovale and/or ductus arteriosus occur in
neonates without recognisable cardiac abnormalities_ It
is often a complication of acute or chronic perinatal
asphyxia, meconium aspiration syndrome, severe hya-
line membrane disease, hyperviscosity, lung hypoplasia
syndromes, and f3-haemolytic streptococcal and other
pneumonias. I·' It is primarily a disease of full-term and
post-term infants and is associated with high morbidity
and mortality rates. Despite aggressive management
with mechanical hyperventilation, plasma volume
expanders and vasopressor drugs, the mortality rate of
PPHN reportedly varies between 34% and 60% (aver-
age 40%)y-6 Alternative modes of therapy, such as
high-frequency oscillatory ventilation and extracorporeal
membrane oxygenation (ECMO), have been suggested
to improve the outcome of neonates whose respiratory
failure is refractory to conventional mechanical ventila-
tion management.'-· ECMO entails the use of a modi-
fied cardiopulmonary bypass circuit to supply temporary
support and lung rest for near-term infants with respira-
toty failure.
ECMO, however, is costly and labour-intensive, the
benefits are controversial, and it has as yet not been
used in developing countries. It is also clear from the
reported experience of some centres that the survival
rate without ECMO is equally good.''''2
In this report we describe the incidence, manage-
ment and short-te·rm outcome of infants with PPHN
who were mechanically ventilated, and discuss the possi-
ble role ofECMO in a developing country.
Patients and methods
The records of all neonates with PPHN who were
admined to the neonatal intensive care unit (1'.lJCU) of
Tygerberg Hospital between June 1986 and October
1990 (53 months) were analysed retrospectively.
PPHN was diagnosed if a clinical suspicion of the
condition existed based on the presence of severe, labile
hypoxaemia disproportionate to the severity of pul-
monary disease (confirmed by a positive response to
hyperoxia-hyperventilation) and/or echocardiography.3
Babies with a congenital diaphragmatic hernia or con-
genital heart lesions were excluded.
------------------------------'---
Results
Statistics
TABLE 11.
Clinical characteristics of the 35 infants with PPHN
TABLE I.
Characteristics of associated conditions in the infants
with PPHN
Range
0,89 - 4,64
28 - 42
2 - 10
3 8,6
1 2,9
1 2,9
1 2,9
2 5,5
3 8,6
1 2,9
35 100
12 34,3
4 11,4
7 20
No. %
19 (54%)
18(51%)
13 (37%)
23:12
11 (31%)
15 (43%)
18:17
2,7 ± 0,88
36,9 ± 3,5
6,9 ± 2,5
9 (26%)
Mean ± SD
Gender (M/F)
Birth weight (kg)
Gestational age (wks)
Apgar (5 min)
Air leaks (pneumothorax)
No. on drug therapy (%)
Tolazoline
Sodium bicarbonate
(weight for volume 4,2%)
Combination therapy
Inborn/outborn
Mortality
Caesarean section
Meconium aspiration syndrome
Asphyxia (no lung disease)
Hyaline membrane disease/pneumonia
Septicaemia
Group B streptococci
Unidentified organism
Pulmonary hypoplasia
Idiopathic pulmonary haemorrhage
Rhesus incompatibility
Transient tachypnoea
Twin-twin transfusion syndrome
Total
Thirty-five neonates with PPHN were evaluated retro-
spectively. Their mean gestational age was 36,9 ± 3,5
weeks at birth with a mean birth weight of 2,67 ± 0,88
kg. Diagnosis was confirmed by the presence of hyper-
oxia-hyperventilation in 43% (15/35), preductal-post-
ductal Pao, difference of> 2 kPa in 11 % (4/35), and by
means of -echocardiography in 40% (14/35) of the
infants. The associated diagnoses of the study popula-
tion are shown in Table I. The infants comprised 1,1 %
of the total admissions to the NICD and represented an
incidence in our population of 1: 1 600 live births during
the study period. Their clinical characteristics are dis-
played in Tables IT and ITl. Comparison of the clinical,
ventilatory and laboratory findings of the survivors v. the
non-survivors (Table IV) showed significant differences
in the mean Pao, (P == 0,02), pH (P == 0,009) and a/A
ratio (P == 0,03) over 10 hours, and highest pH achieved
(P == 0,01), first pH (P == 0,04), and first Pacoz (P ==
0,02). Surviving infants were mechanically ventilated for
5 ± 3 days and received supplemental oxygen for an
additional 6 ± 4 days.
Means and standard deviations were computed for each
of the variables and the differences in numerical data
between groups compared using the two-tailed
Student's Hest. Proportion was compared with the chi-
square test; in cases of small numbers, Fisher's exact
test was used. Statistical significance was accepted at
P < 0,05. The values in the tables are expressed as the
mean of the mean, unless stated otherwise.
Ventilatory and medical management
During the study period the objective of mechanical
ventilation in infants with PPHN was to select the venti-
lator settings necessary to achieve a 'critical' arterial car-
bon dioxide tension (Paco,) which would reverse the
right-ro-left shunt and e~sure an acceptable Pao,
response, Infants were intubated and ventilated with a
conventional time-cycled, pressure-limited infant venti-
lator (Sechrist, model IV 100B, Sechrist, Calif.),
The infants were initially ventilated at high rates
(85 - 1l0/min) to try to achieve the 'critical' Paco, at
the lowest possible inflating pressure. If this approach
failed the ventilation rates were decreased and the inflat-
ing pressure increased, Throughout, we tried to main-
tain the positive end-expiratory pressure below 6 cm
HzO. The fractional concentration of inspired oxygen
was adjusted according to the preductal Oz saturation,
and was kept between 86% and 94%, In all infants the
inspiratory time was "S 0,45 seconds, A continuous infu-
sion of sodium bicarbonate (4,2%) at a rate of 1
mmol/kg/h was administered to infants where a pH ~
7,42 could not be achieved by ventilation alone,
Tolazoline infusion was administered via a peripheral
vein in a bolus of 2 mg/kg followed by a continuous
infusion of 0,3 - 1 mg/kg/h, when the inflating pressure
equalled or exceeded 35 cm HzO, and the alkaline infu-
sion failed to reverse the pulmonary arterial pressure,
The response to this drug was monitored continuously
by means of a transcutaneous Paoz electrode (Nova-
metrix Medical Systems Ine.) and/or pulse-oximeter
(OHMEDA BIOX 3700 pulse oximeter, BOC Health
Care), Prophylactic oral antacid therapy was adminis-
tered to infants receiving tolazoline infusion.
The infants were sedated with intermittent intra-
venous morphine sulphate (0,1 mg/kg) or bolus doses of
fentanyl (2 Ilg/kg), Only 1 of the patients was paralysed.
The mean arterial blood pressure was continuously
monitored and kept ~ 40 - 45 mmHg by means of
continuous cardio-inotropic support (dopamine,
5 - 20 Ilg/kg/min) and bolus infusions of either stabilised
human serum or fresh-frozen plasma (10 - 20 ml/kg).
An attitude of 'minimal' handling was adopted for all
the infants. Infants were aggressively weaned from the .
ventilator as they improved clinically and Paco, levels
between 7 kPa and 9 kPa accompanied by a pH ~ 7,26
accepted.
Each baby's chan was reviewed and the severity of
respiratory failure assessed for the firSt 10 hours after
initiation of conventional mechanical ventilation. The
alveolar-arterial oxygen difference (AaDo,)(kPa), and
arterial alveolar oxygen ratio (a/APo,) we~e calculated
(reflecting the degree of compromise in oxygenation) as
well as the oxygenation index (01) and ventilatory index
(VI 1) (reflecting the severity of respiratory compromise
and the amount of ventilatory support required, respec-
tively).13,l~ These indices were also calculated to evaluate
whether patients who met the criteria for ECMO,,7,8
would have benefited from that therapy, and to assist in
the prediction of outcome, i.e. survival or death, Entry
criteria for ECMO were similar to those used in former
studies for infants weighing more than 2 000 g, with
minor modificationsy,8,1O To qualifY for ECMO, infants
had to fulfil one or more of the following criteria: (z)
average anerial alveolar oxygen ratio "S 0,1; and/or (il)
mean peak inspiratory pressure (PIP) ~ 30 cm H,O
(mean airway pressure (MAP) ~ 15 cm H,O) over the
first 10 hours of mechanical ventilation; (iil) air leaks
(pulmonary interstitial emphysema or pneumothorax;
and (iv) an AaDoz > 80 kPa for> 4 hours.
=-., L...- _
Fio, = fractional concentration of inspired oxygen; PEEP = positive end expiratory
pressure; IPPV -=- intermittent positive pressure ventilation; Ti -=- inspiratory time.
TABLE Ill.
Ventilatory characteristics of the 35 infants with PPHN
during the first 10 hours after initiation of ventilation
(mean ± SO)
Fio2
PIP (cm HP)
PEEP (cm HP)
MAP (cm HP)
Ventilation rate (lmin)
IPPV (d)
PIP (highest value)
Ti (s)
0,93 ± 0,09
29 ± 7,5
4,7± 1,3
15,8 ± 4,3
78,6 ± 11,6
4,8 ± 3,2
35,8 ± 10,1
0,34 ± 0,03
Range
0,66 - 1,0
19 - 46
2-9
7 - 27
40 - 100
1 - 14
20 - 60
0,29 - 0,4
eight infants had a birth weight> 2,0 kg and 16 of them
were eligible for ECMO on the grounds of fulfilling the
entry criteria. Of the abovementioned 16 infants, 4
(25%) died. Their diagnoses included severe lung
hypoplasia with renal dysplasia (N = 1), meconium
aspiration syndrome (N = 1), 13-haemolytic Srreptococcus
(N = 1) and severe refractory asphyxia neonatorum
(N = 1). Excluding the last-mentioned infant (who also
had multi-organ failure and was assessed as having a
condition incompatible with a normal quality of life)
only 2 infants of this group of infants who succumbed,
might ultimately have been saved by means of ECMO
(i.e. the I infant with meconium aspiration syndrome
and the 1 with 13-haemolytic Srreptococcus infection), had
it been available.
TABLE IV.
Profile of survivors v. non-survivors
Survivors Non-survivors
(N=24) (N= 11)
Mean ± SO P-value
Birth weight (g) 2829 ± 790 2334 ± 106O NS
GA (wks) 37,4 ± 3,0 35,7± 4,2 NS
Apgar (5 min). 7,4 ± 2,4 5,8 ± 2,7 NS
Pao2 (kPa)
(mean for 10 h) 10 ± 3,5 7±3 0,02
First Paco2 (kPa) 6,2 ± 1,9 8,0 ± 2,8 0,02
Paco2(mean for 10 h) 5,2 ± 1,0 6±2 NS
Lowest Paco2 (kPa) 3,3 ± 0,8 3,9 ± 1,5 NS
pH (first) 7,20 ± 0,19 7,05 ± 0,18 0,04
pH (mean pH over
10 hours) 7,31 ± 0,1 7,18±0,16 0,009
Highest pH 7,49 ± 0,1 7,36 ± 0,16 0,01
VI1 2396 ± 737 2460 ± 992 NS
AaOo2 (kPa) 72 ± 9,5 74± 12 NS
aJAPo2 0,13±0,05 0,09 ± 0,05 0,03
01 24 ± 14 36±27 NS
GA =gestational age.
Twelve infants were extra-uterine transferrals from
peripheral (level IT) nurseries. Differences between the
inborn and ourbom infants were only found for gesta-
tional age (P =0,04) and birth weight (P =0,02) (Table
V). Seventeen infants (48,5%) were of a gestational age
above 37 weeks and 14 (82%) of them had either meco-
nium aspiration syndrome (N = 12) or asphyxia neo-
natorum (N =2).
TABLEV.
Characteristics of the inborn infants v. outborn infants
(mean ± SO).
Infants
Inborn Outborn
(N=23) (N= 12) P-value
Birth weight (g) 2431 ±918 3139 ± 675 0,02
GA (wks) 36 ± 3,9 38,5± 1,7 0,04
Apgar 5 min 6,5 ± 2,5 7,5 ± 2,7 NS
Survival 15 (65%) 9(75%) NS
MAS 6/23 6/12 NS
aJAPo2 0,12 ± 0,05 0,11 ± 0,06 NS
MAS -=- meconium aspiration syndrome.
Tolazoline was administered to 19 infants (54%) and
resulted in improved oxygenation (positive response) in
47% of cases. Air leaks (pneumothorax) developed in
26% of the infants.
The best markers for a very poor outcome were a
single alAPO, value ~ 0,05 (N =3) (100% mortality) or
an or value? 60 (N = 3) (100% mortality). Twenty-
Discussion
PPHN secondary to meconium aspiration syndrome
and asphyxia is still relatively common in developing
countries such as South Africa. This is partly due to fac-
tors such as no or poor antenatal anendance at clinics,
socio-economic factors, logistic problems such as trans-
port, and incorrect assessment and resuscitation of dis-
tressed infants by anending physicians and/or nursing
staff. Until these conditions can be prevented or recti-
fied, it is important for paediatricians to be familiar with
the diagnosis and treatment of PPHN. To improve sur-
vival rates, these infants must be managed where speci-
fic technology and experience exist. In South Mrica
these facilities are mostly limited to the tertiary institu-
tions, as well as some large provincial and private hospi-
tals.
At Tygerberg Hospital the treatment of infants with
PPHN focuses on mechanical ventilation, as other alter-
natives such as ECMO and high-frequency oscillatory
ventilation are either too expensive or unobtainable.
With this approach the survival rate of 69% in the pre-
sent study compares well with those from similar studies
reported by Hageman et aI.' (71 %) and Bifano and
PfannenstieP5 (72%). Potential problems related to
aggressive mechanical ventilation include acute and
chronic lung injury and the effects of hypocarbia on
cerebral blood flow. I 5-I7 The incidence of pneumothorax
in this study (26%) is lower than that reported by Fox I '
(> 50%), Hageman et aI.' (35%), Wung etaI. IO (40%)
and Kohelet et af.1 (46%). The incidence of broncho-
pulmonary dysplasia among the survivors in the present
study was 3% while 1 infant developed a wheezy chest
after the neonatal period. The abovementioned low fre-
quency of lung sequelae reflects our unit's conservative
approach to positive pressure ventilation, where higher
Paco, values (5,4 ± 1,2 kPa) are regarded as acceptable
during the acute stages of PPHN, and infants are
aggressively weaned during the transitional phase of
their disease. To achieve this, transcutaneous Pao, and
Paco, monitors are continuously utilised. -
This study also showed that non-survivors spent sig-
nificantly more time poorly oxygenated (P = 0,02) and
acidotic (P =0,009) compared with the survivors. This
is probably a reflection of more severe PPHN in the
non-survivors with increased right-to-Ieft shunting
(alAPo, ratio difference significant, P =0,03).
The development of PPHN in the present study
could be. related to a potentially preventable predispos-
ing factor in 80% of the enrolled infants. Meconium
aspiration syndrome was the primary diagnosis in 12
infants (34%) and remains one of the principal, pre-
ventable causative factors in PPHN. Of great concern is
the nearly doubled incidence of meconium aspiration
syndrome among outborn infants (50% v. the 26% inci-
dence (P = NS) in the inborn infants). Since the intro-
duction of ECMO by Bartlen et aI. 9 in 1976, more than
--------------------------'--
3 000 tenn or near-tenn infants have been treated with
this fonn of therapy, resulting in a survival rate of almost
83%. ECMO, however, is not benign or inexpensive, as
the morbidity and incidence of pennanent neurological
injury in patients who undergo ECMO are substantial.
Approximately 10 - 15% of neonates may die and
10 - 30% of surviving infants have an adverse neuro-
developmental outcome.""· The technique of ECMO is
labour-intensive and requires the constant attention of
an experienced physician assisted by trained technolo-
gists and nursing staff.
In conclusion, our data reveal a PPHN incidence of
1,1% of admissions to the NICD, with meconium aspi-
ration syndrome (34%) the leading causative factor.
The survival rate of 69% achieved in the present study
with conventional techniques reflects the trend of
improved survival reponed recently.'· Had ECMO been
available as an alternative mode of therapy at Tygerberg
Hospital, only 2 additional infants might have been
saved (requirement for ECMO: ± 0,6/1 000 live births).
It seems that ECMO has little to offer to improve sur-
vival of infants with PPHN in our situation, and that in
a developing country such as South Africa, it would be
of more value to focus on the improvement of obstetric
and perinatal education programmes."
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Selective posterior lumbosacral rhizotomy for
the management ofcerebral palsy spasticity
A 10-year experience
J. C. PETER, L. J. ARENS
Abstract One hundred and sixty-eight patients had selective
lumbosacral posterior rhizotomies for the treat-
ment of cerebral palsy spasticity at Red Cross War
Memorial Children's Hospital and Groote Schuur
Hospital during the 10-year period 1981 - 1991.
There was no mortality and insignificant early
postoperative morbidity. Long-term follow-up on
110 patients has revealed satisfactory tone reduc-
tion in 95% of cases. The majority showed
improvement in standing, sitting and locomotion.
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Thirteen patients had minor persistent sensory
disturbances and 20% have developed asymp-
tomatic spondylolysis or grade I spondylolisthesis.
Most therapists, patients and parents remain
enthusiastic about the results of this procedure.
S Afr Med J 1993; 83: 745-747.
Selective posterior lumbosacral rhizotomy has beensuccessfully used in the management of spasticityfor almost 100 years. Since Otfrid Foerster's' com-
prehensive description of its use in the treatment of cere-
bral palsy, many refinements have been introduced to
make the procedure more specific for spasticity.'" The
selection of nerve roots by electrical stimulation helps
preserve sensory fibres and consequently minimises
some of the sequelae that were a worry in the pastY-'
